S&P 5007,623.68▼0.5% Nasdaq25,955.34▼0.2% Dow52,215.16▼1.2% Russell 2K2,775.90▼0.3% 10-Yr4.99%+4bp VIX19.45+0.42 WTI$103.44▲4.0% Gold$4,010.00▼1.2% EUR/USD1.120▼0.3% BTC$79,744▼0.3% Nikkei62,908▼2.6%
At close · Sat, Oct 24, 2026
Daily Market Updates.

Global Markets

Home›Global Markets›North America›Chinese biotech giant WuXi AppTec raises 2026 outlook…

Chinese biotech giant WuXi AppTec raises 2026 outlook after profit surge

Reported · Written up by our desk · North America

WuXi AppTec raised its full-year revenue guidance after its net profit surged 62.4 per cent in the first nine months of 2026, while revenue rose 38.6 per cent on strong demand for its drug development and manufacturing services. The Chinese pharmaceutical research services provider’s net profit reached 19.16 billion yuan (US$2.87 billion) for the nine months ended September 30, compared with 11.80 billion yuan a year earlier, a filing to the Hong Kong stock exchange showed. Its revenue rose to...

← Newer storyIt may take real losses to sell AI insurance: CRC Specialty CEO

More like this

Global MarketsAbby Choi’s ex-husband used socialite’s money to live lavishly on mainland: court
Global MarketsHong Kong proposes more homes, less office space at Hung Hom harbourfront
Global MarketsAnthropic’s IPO filing shows explosive growth, risks and staggering costs
Global MarketsAnthropic opens books on AI's explosive growth and staggering costs
Global MarketsAnthropic IPO: It’s official now! Artificial intelligence giant files papers to sell shares to public for first time

Sources

SCMP EconomyChinese biotech giant WuXi AppTec raises 2026 outlook after profit surge

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.